ONDINE BIOMEDICAL INC COM SHS NPV (CDI)ONDINE BIOMEDICAL INC COM SHS NPV (CDI)ONDINE BIOMEDICAL INC COM SHS NPV (CDI)

ONDINE BIOMEDICAL INC COM SHS NPV (CDI)

No trades
See on Supercharts

OBI fundamentals

Key facts

Market capitalization
Founded
CEO
Website
About

Ondine Biomedical, Inc. operates as a life sciences company that develops photodisinfection-based therapies to address drug-resistant infections. Its platform technology called antimicrobial photodynamic disinfection to help prevent and help treat infections across many therapeutic areas in healthcare and industry settings. The firm's novel, patented platform technology both reduces inflammation and eliminates harmful pathogens, rapidly destroying bacteria, fungi and viruses including superbugs and SARS-CoV-2. The company was founded by Carolyn Cross on September 9, 1996 and is headquartered in Vancouver, Canada.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

No dividends
OBI has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company